Arch Pharmalabs gets US Pharmacopeia verification mark
This article was originally published in Scrip
Executive Summary
Arch Pharmalabs, an Indian supplier of active pharmaceuticals ingredients and intermediates, has received a new verification mark for a drug substance, clopidogrel bisulfate (form 1), from the US Pharmacopeia (USP) at its Gurgaon manufacturing facility.